 |
 |
Anyone? I have read an article on email by The National Parkinson Foundation about a product under development by Amgen ( of california) called FKBP. I understand that this product (as of jan 1998) was in phase 1 of development. I have approached the company regarding their current progress with this drug but so far haven't received a reply. Does anyone know what phase the development of this current compound is in and what the current thoughts are regarding it's role as stimulant of nerve regeneration? james pwp